Receive updates from Psychedelics Today for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.
This way you won't miss any new article from Psychedelics Today. Unsubscribe at any time.
Site title: Expert-informed media and education | Psychedelics Today
Is this your feed? Claim it!
Jack Gorsline, investigative journalist, covers four federal developments this week. The Department of Veterans Affairs launched a five-site psilocybin trial, and the drug it runs on belongs to a company preparing an application for approval. The Senate voted to delay the federal hemp THC ban by one month, though the House has not acted. The […]
The post
MAPS co-executive director Ismail Lourido Ali on what the April 2026 executive order, the Texas and Colorado funding fights, and Gabon's new iboga decree mean for who gets access to ibogaine and who benefits from it.
The post Ibogaine...
An Emory study is recruiting 800 people who faced post-psychedelic challenges, to learn what recovery actually takes.
The post The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science appeared first on
Broken glassware from Sasha Shulgin’s historic laboratory is being transformed into art. Megan Bowers and Mikayla Hellwich join Joe Moore to discuss the project, MDMA history, DanceSafe, drug checking, prohibition, and cognitive liberty.
The post
The House attached psychedelic amendments to the FY2027 defense bill, VA Secretary Doug Collins promoted the agency's 20 active trials, and Louisiana began spending opioid settlement money on psychedelic research, with the state claiming 20 percent of profits on anything that comes out of it.
The post